Aeluma Inc. Faces a Crushing Slide Amid Growing Short‑Sellers

Aeluma Inc. (ALMU) has slumped 1.54 % in the last 24‑hour trading session, closing at USD 7.80 on Wednesday, 21 July 2026. The share price, already 43.57 % lower than its month‑end level, continues to deteriorate on a market that has been increasingly hostile. With a market capitalization of only USD 150.3 million and a daily volume of roughly USD 3.7 million, the company has become a magnet for speculative attacks rather than a beacon of long‑term value.

Short‑Sale Blitz: The Invisible Hand of the Capital Markets

The most alarming development is the wave of disclosed short‑sale positions filed in the German Federal Gazette. Between 17 and 31 July, multiple investment houses—Bronte Capital, Mangrove Partners, Arrowstreet Capital, Walleye Capital, and others—publicly reported short positions that collectively amount to less than one percent to a little over one percent of Aeluma’s issued capital. Although the absolute numbers may appear modest, the frequency and convergence of these positions signal a coordinated effort to pressure the stock.

Each filing indicates that the short sellers hold their positions on the same day, implying a strategic, synchronized approach rather than opportunistic trading. No corporate action or earnings announcement accompanies these filings, meaning the decline is driven not by fundamentals but by market sentiment and speculation.

Technical Warnings: A Price Path to Descent

Aeluma’s 200‑day simple moving average sits at USD 17.21, a level the share is well below, confirming a bearish trend. The 52‑week high of USD 31.79 was reached on 13 May 2026, while the 52‑week low of USD 7.38 materialized on 20 October 2026—precisely in the range where the current price now trades. The proximity to the recent low suggests that the stock is on the brink of a deeper collapse unless a decisive catalyst emerges.

Comparisons with Peer Performances

Aeluma is not alone in the decline. Within the same 24‑hour window, other mid‑cap names have shown mixed fortunes:

  • Triplepoint Venture Growth B (TPVG) – down 2.05 % to USD 4.27, market cap USD 178.3 million, P/E 4.4.
  • Brc (RILYP) – down 4.89 % to USD 7.68, market cap USD 178.5 million, P/E 0.49.
  • James River I (JRVR) – up 0.26 % to USD 3.90, market cap USD 178.5 million, P/E 7.54.
  • Gp‑act Iii Acquisition (GPAT) – down 0.09 % to USD 11.07, market cap USD 179.1 million.
  • Invivyd (IVVD) – up 4.43 % to USD 0.67, market cap USD 179.8 million.

While some peers have managed marginal gains or stability, Aeluma’s continued slide underscores a lack of intrinsic support and an inability to counteract the mounting short‑selling pressure.

The Bottom Line: A Call for Vigilance

Aeluma Inc.’s recent trajectory illustrates the peril of a stock that is increasingly targeted by short sellers without substantive defensive measures. Its market cap, trading volume, and price relative to historical highs and lows paint a grim picture for investors seeking sustainable growth. The company’s presence on the OTC Bulletin Board—an environment already prone to volatility—adds another layer of risk.

For investors, the message is clear: unless Aeluma can deliver a compelling strategic turnaround, the stock is poised for further erosion. Those who have already invested may wish to reassess their positions in light of the aggressive short‑selling landscape and the technical signals that confirm a bearish bias.